Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
elox
/
Eloxx Pharmaceuticals Ord Shs
ELOX
Add to Watchlist
17.370
USD
+4.070
+30.60%
Close 07-31 16:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
8.01M
Market Cap
--
P/E TTM
Eloxx Pharmaceuticals Ord Shs
17.370
+4.070
+30.60%
Overview
Financials
Discussions
Analysis
Company
Profile
Overview
Financials
Discussions
Analysis
Company
Profile
More Details of Company
Eloxx Pharmaceuticals Ord Shs Info
Ticker Symbol
- -
Company name
- -
IPO date
- -
CEO
- -
Number of employees
- -
Security type
- -
Fiscal year-end
- -
Address
- -
City
- -
Stock exchange
- -
Country
- -
Postal code
- -
Phone
- -
Website
- -
Ticker Symbol
- -
IPO date
- -
CEO
- -
Company Executives of Eloxx Pharmaceuticals Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.66K
+19.39%
Mr. Steven Rubin, J.D.
Mr. Steven Rubin, J.D.
Independent Director
Independent Director
--
--
Dr. Alan E. Walts, Ph.D.
Dr. Alan E. Walts, Ph.D.
Independent Director
Independent Director
--
--
Mr. Daniel E. (Dan) Geffken, CPA
Mr. Daniel E. (Dan) Geffken, CPA
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. John Woolford
Mr. John Woolford
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Stephen W. Webster
Mr. Stephen W. Webster
Independent Director
Independent Director
--
--
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
188.66K
+19.39%
Mr. Steven Rubin, J.D.
Mr. Steven Rubin, J.D.
Independent Director
Independent Director
--
--
Dr. Alan E. Walts, Ph.D.
Dr. Alan E. Walts, Ph.D.
Independent Director
Independent Director
--
--
Mr. Daniel E. (Dan) Geffken, CPA
Mr. Daniel E. (Dan) Geffken, CPA
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. John Woolford
Mr. John Woolford
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Stephen W. Webster
Mr. Stephen W. Webster
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Eloxx Pharmaceuticals Ord Shs?
The top five shareholders of Eloxx Pharmaceuticals Ord Shs are: Mr. Sumit Aggarwal